Sweden's Elekta secures linacs order in UK PFI (private finance initiative) deal
This article was originally published in Clinica
Swedish radiation oncology and neurosurgery specialist Elekta has secured a UK order for 10 linear accelerators (linacs), under a £220m ($405m) private finance initiative (PFI) to build and equip a new wing at St James Hospital, in Leeds (Yorkshire). The linacs feature Elekta's Synergy system, which enables 2D kV planar or 3D X-ray volume imaging of the patient in the treatment position. The system includes Elekta's Active Breathing Coordinator system, which helps to target tumours that move due to respiration.
You may also be interested in...
A Phase III trial testing the antibody-drug conjugate sacituzumab govitecan was stopped early for efficacy, boding well for the BLA pending at the US FDA.
Deal Snapshot: Six companies seek to collect convalescent plasma from COVID-19 survivors to quickly develop hyperimmune immunoglobulin therapy for serious complications of the virus.
Pharmaceutical companies struggling to keep up with coronavirus-related supply chain havoc asked to keep the US regulator informed as situation unfolds.